Skip to main content
. 2013 Jan 31;108(4):908–913. doi: 10.1038/bjc.2013.22

Table 3. Summary of discordant results between different tests.

  BD HPV Roche Cobas Qiagen Hybrid Capture 2 Abbott RealTime High Risk HPV Gen-Probe APTIMA NorChip PreTect HPV-Proofer
BD HPV

0.83
0.78
0.81
0.65
0.33
Roche Cobas
(145, 134)a

0.75
0.85
0.64
0.35
 
1.1 (0.8, 1.4)
 
 
 
 
 
Qiagen Hybrid Capture 2
(204, 141)
(225, 174)

0.78
0.68
0.35
 
1.4 (1.2, 1.8)
1.3 (1.1, 1.6)
 
 
 
 
Abbott RealTime High Risk HPV
(227, 57)
(194, 35)
(216, 108)

0.70
0.39
 
4.0 (3.0, 5.4)
5.5 (3.9, 8.2)
2.0 (1.6, 2.5)
 
 
 
Gen-Probe APTIMA
(421, 70)
(414, 77)
(353, 68)
(279, 97)

0.45
 
6.0 (4.7, 7.9)
5.4 (4.2, 6.9)
5.2 (4.0, 6.8)
2.9 (2.3, 3.7)
 
 
NorChip PreTect HPV-Proofer
(684, 61)
(670, 54)
(625, 63)
(532, 65)
(375, 82)

  11.2 (8.6, 14.8) 12.4 (9.4, 16.7) 9.9 (7.6, 13.1) 8.2 (6.3, 10.8) 4.6 (3.6, 5.9)  

Number in top half of Table represent kappa values. Numbers in bottom half of Table give discordant pairs (column positive/row negative vs column negative/row positive) and OR (95% CI).

a

145 Tested positive for BD HPV and negative for Roche Cobas, and 134 tested negative for BD HPV and positive for Roche Cobas.